NATIONAL JEWISH HEALTH
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Completed
- Conditions
- Hyper Dynamic Airway Collapse (HDAC)Obstructive Sleep Apnea (OSA)Trachebronchomalacia (TBM)
- First Posted Date
- 2014-03-27
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 1
- Registration Number
- NCT02097212
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2014-02-27
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 200
- Registration Number
- NCT02073409
- Locations
- ๐บ๐ธ
CFF Adult Program, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
๐บ๐ธUniversity of Vermont Medical Center, Burlington, Vermont, United States
๐บ๐ธCFF Adult Program, University of Washington, Seattle, Washington, United States
Supplemental Oxygen in Pulmonary Fibrosis
Completed
- Conditions
- Pulmonary Fibrosis
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2020-02-25
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 19
- Registration Number
- NCT01961362
- Locations
- ๐บ๐ธ
National Jewish Health Interstitial Lung Disease Program, Denver, Colorado, United States
FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults
Not Applicable
Completed
- Conditions
- Hand Dermatitis
- Interventions
- Other: fiteBac Hand Sanitizer
- First Posted Date
- 2013-09-25
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 22
- Registration Number
- NCT01950494
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
Completed
- Conditions
- Peanut AllergyMilk AllergyEgg Allergy
- Interventions
- Procedure: Oral food challenge
- First Posted Date
- 2013-09-25
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 102
- Registration Number
- NCT01950533
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Pulmonary Fibrosis Contact Registry
Completed
- Conditions
- Pulmonary Fibrosis of Any CausePrimary Supporters/Caretakers of Patients With Pulmonary Fibrosis
- First Posted Date
- 2013-09-05
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 300
- Registration Number
- NCT01935726
- Locations
- ๐บ๐ธ
National Jewish Health Interstitial Lung Disease Program, Denver, Colorado, United States
Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution
Completed
- Conditions
- Cystic Fibrosis in Adults, Chronic Colonization With Pseudomonas Aeruginosa
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2020-03-24
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 23
- Registration Number
- NCT01736839
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
Not Applicable
Completed
- Conditions
- High Risk of Developing Lung Cancer
- Interventions
- Other: CT scan & Early CDT Lung test
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2020-12-31
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 1361
- Registration Number
- NCT01700257
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Completed
- Conditions
- Asthma
- First Posted Date
- 2012-05-01
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 110
- Registration Number
- NCT01589198
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis
Not Applicable
Completed
- Conditions
- Pulmonary Sarcoidosis
- Interventions
- Dietary Supplement: N-acetyl-cysteineDrug: Placebo
- First Posted Date
- 2012-04-27
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 17
- Registration Number
- NCT01587001
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath